VIRGINIA BEACH, Va., Feb.17, 2014 /PRNewswire-USNewswire/ -- Rony Thomas, President and CEO of LifeNet Health, is presenting at the 9th Annual Stem Cell Summit in New York City on February 18, 2014. The annual Stem Cell Summit brings key leaders in the medical, scientific and business innovators in this growing space of technology and regenerative medicine. Mr. Thomas' presentation, "Allograft Cellular Products - First Mover Advantage" will focus on how LifeNet Health has applied its experience and institutional knowledge about safety and efficacy in the cell-based product market - the fastest-growing segment in the bone graft substitute market.
(Logo: http://photos.prnewswire.com/prnh/20140217/DC66506LOGO)
"The use of a variety of forms of donated tissues has worked for decades to save lives and restore health in many surgical disciplines. Now we are developing cellular therapies, tissue engineering and new medical applications for allografts to treat disease and assist in the development of lifesaving drugs. Our LifeNet Health Institute of Regenerative Medicine is the physical embodiment of our commitment to future development in the cellular therapies arena," stated Mr. Thomas.
About LifeNet Health
LifeNet Health helps to save lives and restore health for thousands of patients each year. We are the world's most trusted provider of transplant solutions, from organ procurement to new innovations in bio-implant technologies and cellular therapies-a leader in the field of regenerative medicine, while always honoring the donors and healthcare professionals that allow the healing process.
About the LifeNet Health Institute of Regenerative Medicine
The LifeNet Health Institute of Regenerative Medicine is a division of LifeNet Health located in Virginia Beach, Virginia. The Institute houses medical, scientific, and research staff members and focuses on the science of developing regenerative medicine products for patients all over the world. It serves as a global center of excellence for research and development focused on cellular therapies, tissue engineering, and new medical applications for allografts to maximize the gift of donation.
SOURCE LifeNet Health
